skip to content

Cancer Research UK Cambridge Institute

Authors Research group E-pub datesort ascending Journal name Citation info
Germline whole exome sequencing and large-scale replication identifies FANC... E. Dicks, H. Song, S.J. Ramus, E. Van Oudenhove, J.P. Tyrer, M.P. Intermagg... Brenton Group 14 Apr 2017 Oncotarget n/a
Identification of 12 new susceptibility loci for different histotypes of ep... C.M. Phelan, K.B. Kuchenbaecker, J.P. Tyrer, S.P. Kar, K. Lawrenson, S.J. W... Brenton Group 28 Mar 2017 Nat Genet n/a
Liquid biopsies come of age: towards implementation of circulating tumour D... J.C. Wan, C. Massie, J. Garcia-Corbacho, F. Mouliere, J.D. Brenton, C. Cald... Brenton Group, Caldas Group, Rosenfeld Group 25 Feb 2017 Nat Rev Cancer n/a
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/... H. Xu, M. Di Antonio, S. McKinney, V. Mathew, B. Ho, N.J. O'Neil, N.D.... Balasubramanian Group, Brenton Group, Caldas Group 18 Feb 2017 Nat Commun 8():14432
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomark... C.A. Parkinson, D. Gale, A.M. Piskorz, H. Biggs, C. Hodgkin, H. Addley, S. ... Brenton Group, Rosenfeld Group 20 Dec 2016 PLoS Med 13(12):e1002198
Development of Cell-Permeable, Non-Helical Constrained Peptides to Target a... M.M. Wiedmann, Y.S. Tan, Y. Wu, S. Aibara, W. Xu, H.F. Sore, C.S. Verma, L.... Brenton Group 6 Dec 2016 Angew Chem Int Ed Engl n/a
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARI... E.M. Swisher, K.K. Lin, A.M. Oza, C.L. Scott, H. Giordano, J. Sun, G.E. Kon... Brenton Group 3 Dec 2016 Lancet Oncol n/a
Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutatio... M. Kobel, A.M. Piskorz, S. Lee, S. Lui, C. LePage, F. Marass, N. Rosenfeld,... Brenton Group, Rosenfeld Group 15 Nov 2016 J Pathol Clin Res 2(4):247-58
SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellul... D.A. Tumbarello, M.R. Andrews and J.D. Brenton Brenton Group 14 Sep 2016 PLoS One 11(9):e0162698
Sequencing Structural Variants in Cancer for Precision Therapeutics G. Macintyre, B. Ylstra and J.D. Brenton Brenton Group 3 Aug 2016 Trends Genet n/a